TY - JOUR
T1 - Nephrotoxicity from cancer immunotherapy
AU - Dosik, G. M.
AU - Gutterman, J. U.
AU - Hersh, E. M.
AU - Akhtar, M.
AU - Sonoda, T.
AU - Horn, R. G.
PY - 1978
Y1 - 1978
N2 - Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.
AB - Because systemic intravenous immunotherapy with Corynebacterium parvum is an effective immunopotentiating and immunotherapeutic agent in animals, clinical studies of this agent have been undertaken. Toxicities in man have been noted, but most are treated symptomatically. Three patients with metastatic melanoma developed oliguria, edema, diffuse bilateral pulmonary infiltrates, azotemia, hypoalbuminemia and hypocomplementemia, while receiving intravenous C. parvum therapy. All had renal biopsies that showed a proliferative glomerulonephritis with subendothelial basement membrane deposits. Immunofluorescence showed glomerular IgG, IgA, IgM, and the C3 component of complement. A fourth patient was found in retrospective chart review of 87 patients registered on two C. parvum-containing protocols. The frequency of the complication in this group was 3/87. Renal failure resolved in all four patients spontaneously after the cessation of C. parvum immunotherapy. Serial evaluation of renal function should be carried out in all patients on systemic adjuvant immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0017826289&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017826289&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-89-1-41
DO - 10.7326/0003-4819-89-1-41
M3 - Article
C2 - 666183
AN - SCOPUS:0017826289
VL - 89
SP - 41
EP - 46
JO - Nuclear Physics A
JF - Nuclear Physics A
SN - 0375-9474
IS - 1
ER -